Drug Development

Articles

Stevanato Group has extended its licensing agreement with Haselmeier for its Axis-D pen injector technology.

Stevanato Group, Haselmeier Extend Licensing Agreement for Pen Injector Technology

A report by international regulators reviews the effectiveness of current COVID-19 vaccines against the omicron variant.

COVID-19 Vaccination Offers Protection from Hospitalization due to Omicron Variant, According to Report

Hallie Forcinio is packing editor for Pharmaceutical Technology and Pharmaceutical Technology Europe, editorhal@sbcglobal.net.

Protective external packaging ensures COVID-19 vaccines arrive safely. 

Sustainable Shippers for Ultra-Cold Conditions

The agreement expands Pfizer’s access to LNP formulation technology for mRNA vaccines and therapeutics.

Pfizer and Acuitas Therapeutics Collaborate on Lipid Nanoparticle Delivery System 

Intravacc is partnering with Leiden University Medical Center for the development and evaluation of a new intranasal coronavirus vaccine candidate in a clinical Phase I/II study. 

Clinical Trial on Intranasal Coronavirus Vaccine Set to Start

With this investment into Yapan Bio, Piramal Pharma adds new technologies and capabilities in large molecules, including vaccines and gene therapies, to its global offering.

Piramal Pharma Invests Minority Stake in India-Based CDMO, Yapan Bio

Michael Moedler, PhD, is head of Training at Lonza Biologics Operations Visp.

Helene Pora, PhD, is vice-president of Technical Communication and Regulatory Strategy at Pall Corporation.

Workforce training is crucial for biopharmaceutical manufacturing.

Addressing the Training Gap for Single-Use Technologies

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Dosage form and patient needs drive excipient choice.

Taste and Appearance: Selecting the Right Excipients 

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Poor solubility remains a big issue for drug development and, as such, is driving innovation in approaches and use of novel technologies to help overcome the associated challenges.

Tackling the Big Issue of Solubility

Cheryl Barton is director of PharmaVision, 

DTx manufacturers are taking advantage of the new regulatory flexibility, afforded by the COVID-19 pandemic, to pilot new products and generate real-world evidence to support regulatory filing and reimbursement.

Formulation and Drug Delivery